We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


SensiQ, Inventiva Set Up a European SPR Center of Excellence

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "SensiQ, Inventiva Set Up a European SPR Center of Excellence"

Listen with
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.
Read time:

SensiQ and Inventiva have announced the launch of a European Center of Excellence in SPR technologies, using SensiQ® Pioneer Fragment Edition (Pioneer FE) instrumentation.

The SPR Center of Excellence is based in Dijon, France. Inventiva’s existing pharmaceutical discovery platform will now include SensiQ SPR technology, which strengthens Inventiva’s current service offering.

The new Center also allows SensiQ to offer prospective customers on-site demonstrations at Inventiva’s offices. Inventiva’s entire team will benefit from the extensive SPR experience from the SensiQ dedicated support staff.

“The Center of Excellence will provide additional technological capabilities to our partners. It also enhances our extensive HTS and HCS screening platforms, which, combined with our proprietary library, provide one of the most compelling offerings available on the market”, said Frederic Cren, co-founder and CEO of Inventiva. “We look forward to using the SensiQ Pioneer equipment. It provides us with a powerful tool to measure binding interactions and accelerate drug discovery for our partners”, said Pierre Broqua, co-founder and CSO of Inventiva.

“The newly released Pioneer FE represents a new paradigm in capability and performance. We are thrilled that Inventiva has chosen to make it the centerpiece of the SPR Center of Excellence in Dijon”, said Colin Cumming, CEO of SensiQ.